Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)

NCT01662687 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)

Interventions

DRUG: Sancuso patch
DRUG: Kytril inj.+Kytril tab.

Sponsor

LG Life Sciences